The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[4-[2-[(4-oxo-3H-phthalazin-1-yl)amino]ethyl]phenyl]-3-(trifluoromethyl)benzamide ID: ALA4761439
PubChem CID: 162514676
Max Phase: Preclinical
Molecular Formula: C24H19F3N4O2
Molecular Weight: 452.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)c1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C24H19F3N4O2/c25-24(26,27)17-5-3-4-16(14-17)22(32)29-18-10-8-15(9-11-18)12-13-28-21-19-6-1-2-7-20(19)23(33)31-30-21/h1-11,14H,12-13H2,(H,28,30)(H,29,32)(H,31,33)
Standard InChI Key: XWSOAVQNXFDLPY-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
18.5390 -20.9870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2484 -20.5825 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2484 -19.7612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5390 -19.3443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5390 -21.8083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5390 -18.5230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2509 -18.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8338 -20.5825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8363 -19.7630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1290 -19.3528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4187 -19.7610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4201 -20.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1280 -20.9901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9575 -18.5248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6663 -18.1180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3688 -18.5305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0770 -18.1244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0795 -17.3064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3679 -16.8961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6626 -17.3046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7877 -16.8986 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.4950 -17.3080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4940 -18.1252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2032 -16.9003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9064 -17.3119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6141 -16.9048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6156 -16.0867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9034 -15.6774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1986 -16.0869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3212 -17.3146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3198 -18.1318 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.0296 -16.9071 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.0251 -17.7223 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9 4 1 0
8 1 1 0
1 2 1 0
2 3 1 0
3 4 2 0
1 5 2 0
4 6 1 0
6 7 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
7 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
21 22 1 0
22 23 2 0
22 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
26 30 1 0
30 31 1 0
30 32 1 0
30 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 452.44Molecular Weight (Monoisotopic): 452.1460AlogP: 4.85#Rotatable Bonds: 6Polar Surface Area: 86.88Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.87CX Basic pKa: 3.69CX LogP: 4.45CX LogD: 4.44Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: -1.56
References 1. Zhang XJ,Xu Y,Mou HX,Wang S,Hao SY,Chen SW. (2020) The synthesis and anti-tumour properties of novel 4-substituted phthalazinones as Aurora B kinase inhibitors., 30 (23.0): [PMID:32941989 ] [10.1016/j.bmcl.2020.127556 ]